These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 28984423
1. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia. Rahman K, Gupta R, Singh MK, Sarkar MK, Gupta A, Nityanand S. Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423 [Abstract] [Full Text] [Related]
2. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia. Mosleh M, Mehrpouri M, Ghaffari S, Saei Z, Agaeipoor M, Jadali F, Satlsar ES, Gholampour R. Scand J Clin Lab Invest; 2020 Apr; 80(2):87-92. PubMed ID: 31829759 [Abstract] [Full Text] [Related]
3. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities. Dong HY, Kung JX, Bhardwaj V, McGill J. Am J Clin Pathol; 2011 Jan; 135(1):76-84. PubMed ID: 21173127 [Abstract] [Full Text] [Related]
4. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations. Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF. Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014 [Abstract] [Full Text] [Related]
5. [Immunophenotypic Analysis of Acute Promyelocytic Leukemia]. Chen F, Hu YP, Wang XH, Fu S, Fu Y, Liu X, Zhang MY, Wang SK, Zhang JH. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):321-5. PubMed ID: 27150985 [Abstract] [Full Text] [Related]
6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS, Eastern Cooperative Oncology Group. Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165 [Abstract] [Full Text] [Related]
7. The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia. Tran VT, Phan TT, Mac HP, Tran TT, Ho TT, Pho SP, Nguyen VN, Vo TM, Nguyen HT, Le TT, Vo TH, Nguyen ST. BMC Res Notes; 2020 Aug 26; 13(1):394. PubMed ID: 32847610 [Abstract] [Full Text] [Related]
8. The CD9+ CD11b- HLA-DR- immunophenotype can be used to diagnose acute promyelocytic leukemia. Ren F, Zhang N, Xu Z, Xu J, Zhang Y, Chen X, Tan Y, Chang J, Wang H. Int J Lab Hematol; 2019 Apr 26; 41(2):168-175. PubMed ID: 30315692 [Abstract] [Full Text] [Related]
9. Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations. Promsuwicha O, Auewarakul CU. Asian Pac J Allergy Immunol; 2009 Dec 26; 27(4):209-16. PubMed ID: 20232575 [Abstract] [Full Text] [Related]
10. [Expressions of CD117 and CD11b in patients with APL at diagnosis and post-treatment]. Shen HQ, Tang YM, Song H, Shi SW, Yang SL, Xu WQ, Qian BQ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug 26; 14(4):644-8. PubMed ID: 16928291 [Abstract] [Full Text] [Related]
11. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F, Chen Y. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 26; 15(4):687-91. PubMed ID: 17708783 [Abstract] [Full Text] [Related]
12. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia]. Sun HM, Qian SX, Wu YJ, Qiao C, Hong M, Fan L, Yang H, Zhang JF, Zhang SJ, Wu HX, Qiu HX, Lu H, Xu W, Sheng RL, Li JY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb 26; 17(1):176-9. PubMed ID: 19236773 [Abstract] [Full Text] [Related]
14. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia]. Wang YZ, Chang Y, Zhu HH, Qin YZ, Li JL, Fu JY, Li LD, Chen SS, Huang XJ, Lu DP, Liu YR. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun 26; 14(3):427-32. PubMed ID: 16800913 [Abstract] [Full Text] [Related]
15. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD. Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211 [Abstract] [Full Text] [Related]
16. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia]. Liu Y, Chen YT, Li JX, Zhang SH. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug 01; 20(4):806-11. PubMed ID: 22931633 [Abstract] [Full Text] [Related]
18. HLA-DR antigen-positive acute promyelocytic leukemia. Mendoza AS, Qing X, Dungo M, Lasky J, Panosyan E, Cai J. Exp Mol Pathol; 2016 Oct 01; 101(2):197-200. PubMed ID: 27544027 [Abstract] [Full Text] [Related]
19. Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid. Horna P, Zhang L, Sotomayor EM, Lancet JE, Moscinski LC. Am J Clin Pathol; 2014 Oct 01; 142(4):546-52. PubMed ID: 25239423 [Abstract] [Full Text] [Related]